Beijing Science Sun Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002110
CNY
11.52
0.05 (0.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
409.48
469.17
725.71
1,039.07
1,084.00
1,179.83
1,409.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
409.48
469.17
725.71
1,039.07
1,084.00
1,179.83
1,409.03
Raw Material Cost
156.83
157.53
187.89
207.72
210.23
196.21
208.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.06
0.03
0.26
0.29
0.14
0.11
Selling and Distribution Expenses
187.11
280.26
419.04
637.31
681.26
802.06
884.64
Other Expenses
4.04
7.18
9.49
9.82
6.80
4.91
3.08
Total Expenditure (Excl Depreciation)
384.29
509.65
701.90
943.53
959.78
1,047.49
1,124.19
Operating Profit (PBDIT) excl Other Income
25.2
-40.5
23.799999999999997
95.5
124.2
132.3
284.8
Other Income
15.66
14.90
51.32
66.36
42.97
44.18
49.83
Operating Profit (PBDIT)
85.60
23.35
122.73
217.58
203.24
197.90
357.53
Interest
0.00
0.06
0.03
0.26
0.29
0.14
0.11
Exceptional Items
-56.39
100.69
125.37
185.65
14.81
6.57
0.00
Gross Profit (PBDT)
252.65
311.64
537.82
831.35
873.78
983.62
1,200.42
Depreciation
47.25
48.74
47.60
55.68
36.96
25.85
22.75
Profit Before Tax
-18.04
75.25
200.47
347.30
180.80
178.49
334.66
Tax
-6.69
25.76
51.97
43.89
28.01
25.18
47.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-68.85
102.92
204.73
402.27
154.90
148.64
283.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-68.85
102.92
204.73
402.27
154.90
148.64
283.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.02
-6.51
-2.09
-7.14
-3.62
-1.08
0.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-76.87
96.41
202.65
395.13
151.28
147.55
283.16
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,357.11
3,436.01
3,373.90
3,244.74
2,804.43
2,674.10
2,551.82
Earnings per share (EPS)
-0.14
0.21
0.43
0.84
0.32
0.31
0.59
Diluted Earnings per share
-0.14
0.21
0.43
0.84
0.32
0.31
0.59
Operating Profit Margin (Excl OI)
5.54%
-8.59%
3.28%
9.19%
11.38%
10.84%
20.22%
Gross Profit Margin
7.13%
26.43%
34.18%
38.78%
20.09%
17.32%
25.37%
PAT Margin
-16.81%
21.94%
28.21%
38.71%
14.29%
12.6%
20.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -12.72% vs -35.35% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -179.77% vs -52.42% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 722.35% vs -88.10% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -100.00% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Beijing Science Sun Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
409.48
0
409.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
409.48
0
409.48
Raw Material Cost
156.83
0
156.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
187.11
0
187.11
Other Expenses
4.04
0.00
4.04
Total Expenditure (Excl Depreciation)
384.29
0
384.29
Operating Profit (PBDIT) excl Other Income
25.19
0.00
25.19
Other Income
15.66
0
15.66
Operating Profit (PBDIT)
85.60
0
85.60
Interest
0.00
0
0.00
Exceptional Items
-56.39
0
-56.39
Gross Profit (PBDT)
252.65
0
252.65
Depreciation
47.25
0
47.25
Profit Before Tax
-18.04
0
-18.04
Tax
-6.69
0
-6.69
Provisions and contingencies
0
0
0.00
Profit After Tax
-68.85
0
-68.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-68.85
0
-68.85
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.02
0
-8.02
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-76.87
0
-76.87
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,357.11
0
3,357.11
Earnings per share (EPS)
-0.14
0
-0.14
Diluted Earnings per share
-0.14
0
-0.14
Operating Profit Margin (Excl OI)
5.54%
0%
0.00
5.54%
Gross Profit Margin
7.13%
0%
0.00
7.13%
PAT Margin
-16.81%
0%
0.00
-16.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 40.95 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -12.72% vs -35.35% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit -7.69 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -179.77% vs -52.42% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 722.35% vs -88.10% in Dec 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.54%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023